Diversity of Toxin Genotypes and Antimicrobial Susceptibility of Clostridium perfringens Isolates from Feces of Infants

Abstract

Introduction: This study investigated the most important epidemiological characteristics of C. perfringens strains colonizing the intestine of Jordanian infants. Methods: A total of 302 fecal samples were collected from Jordanian infants aged ≤ 1 year from patients hospitalized in the neonatal intensive care unit and from the outpatient department. Samples were cultured for detection of C. perfringens and evaluation of their antimicrobial resistance; identification of their potential toxins genes was performed using PCR. Results: Overall the C. perfringens colonization rate was 27.2% (82/302). Infants aged ≤ 6 months showed significantly higher (p < 0.004) colonization than older infants. The occurrence rates of C. perfringens isolates carrying potential specific toxin genes were as follows: alpha toxin 95.1% (78/82), beta-2 toxin 69.5% (57/82), beta toxin 14.6% (12/82), and only 2.4% (2/82) epsilon toxin. No isolate carried the iota toxin. Genotype A was the most prevalent among C. perfringens isolates (78.1%). The antimicrobial resistance rates of C. perfringens isolates were 20% to metronidazole and erythromycin, 16.7% to levofloxacin, and 6.7% to vancomycin. Conclusions: This study demonstrates that the majority of C. perfringens isolates from feces of Jordanian infants were classified as type A, few isolates were classified as type C and type D, and all were negative for potential enterotoxin genes causing diarrhea.

Introduction

Clostridium perfringens is a Gram-positive, non-motile, anaerobic bacillus widely present in the gastrointestinal tract of healthy humans and animals [1,2]. C. perfringens has been associated with a wide variety of pathological conditions that include gas gangrene, necrotic enteritis, food poisoning and sporadic cases of antibiotic-associated diarrhea [3,4].

The importance of this organism arises from its ability to produce many toxins. Various combinations of C. perfringens toxin genes are localized on either the chromosome or within transferable plasmids that may possess lethal hemolytic and necrotizing properties [5].

The association of many toxin genes with insertion sequences and conjugative plasmids enhances the virulence of the organism in causing intestinal infections [6].

C. perfringens strains carrying enterotoxin (CPE) gene on the chromosome are more heat-resistant than those carrying this gene on a plasmid; these are associated with human foodborne disease [5]. Currently, there are five different confirmed toxigenic types of C. perfringens, named A-E [5,7]. However, a recent study has reported that two additional candidates of toxinotypes may be included in a future list [8].

This study investigated the occurrence rate of C. perfringens isolates and their potential toxins in fecal samples of Jordanian infants aged ≤ 1 year using culture and polymerase chain reaction (PCR) procedure.

Methods

Study design and population

This cross-sectional study included 302 infants ≤ 1 year of age in the Pediatrics Department, The Jordan University Hospital (JUH) in Amman, Jordan, over a 10-month period from May 2016 through February 2017. A total of 302 fresh fecal samples from soiled diapers were collected randomly using cotton swabs from infants hospitalized in the neonatal intensive care unit (NICU) or examined in the outpatient department (OPD). All fecal specimens were sent within 2-3 h to research microbiology labs. For each sample, the following data were recorded: date of collection, patient number, hospital ward, mode of delivery, infant’s name, sex, age, birth weight, type of feeding, presence of diarrhea, and the recent use of one or more antibiotics. Permission for the study was obtained from the Ethical Review Board (ERB) at the JUH, no. 118/May 2016. Verbal consent was obtained from all mothers of infants after explaining the aim of the study.

Culture and identification

Fresh fecal samples were treated by absolute ethanol (v/v) for 1 hour before inoculation onto Perfringens Tryptose-Sulphite-Cycloserine (TSC) agar plates with egg-yolk (EY) (Oxoid, Altrincham, England). Samples were carefully mixed, and 0.1 mL inoculum was directly inoculated on EY-TSC agar plates and incubated in anaerobic jar for 48 hours at 37°C by using Anaerobe bag (AnaeroGen AN25; Oxoid). All suspected colonies resembling C. perfringens which appeared black and surrounded by egg yolk precipitate were examined by the catalase-negative reaction. Five to ten colonies suspected to be C. perfringens were picked from each plate and streaked on blood agar plates (Oxoid) supplemented with human blood (5%), and incubated for 48 h at 37°C under anaerobic conditions. All isolates that formed white colonies surrounded by hemolysis and displayed Gram-positive rod shape with subterminal spores were identified primarily as C. perfringens isolates [9]. C. perfringens control strain (CMUL Clo. Per. SL IX-004) was obtained from Prof. Monzer Hamze, Laboratoire de Microbiologie Santé et Environnement (LMSE), Faculty of Public Health, Lebanese University, Tripoli, Lebanon. The control strain contains the toxins alpha, beta and epsilon and was included for quality control in biochemical identification of C. perfringens isolates, antibiotic susceptibility and as a positive control in genetic identification of C. perfringens toxins. All 82 C. perfringens isolates were inoculated in 1.8 mL of brain-heart infusion broth (Oxoid) with 20% glycerol and were stored at -70°C for further characterization of the toxin genes.

Antimicrobial susceptibility testing

All C. perfringens isolates were tested using E-test. The minimum inhibitory concentration (MIC) breakpoints were used to indicate the resistance to each tested drug according to the recommendation of the Clinical and Laboratory Standards Institute (CLSI) [10].

DNA and plasmid extraction

All C. perfringens isolates stored in cryogenic tubes at -70°C were thawed at room temperature and cultured onto TSC agar. After incubation at 37°C for 48 h, a few colonies (6-7 colonies) were picked from the agar and inoculated into 5 mL Mueller Hinton broth and incubated at 37°C overnight. According to the manufacturer’s protocol, the bacterial DNA was isolated using Wizard Genomic DNA purification kit (Promega, Madison, WI, USA); bacterial plasmid was extracted using EZ-10 Spin Column Plasmid DNA Minipreps Kit (Bio Basic, Markham, ON, Canada).

16S rDNA confirmation for C. perfringens identification

PCR confirmation for C. perfringens isolates was performed by amplification of the 16S rRNA gene using C. perfringens specific primers (

Table 1. Oligonucleotide primer sequences used in this study.

). The PCR assay was performed at the final volume of 20 µL using the following mixture: 4 µL of KAPPA Fast ready mix (5X) master mix (Solis BioDyne, Tartu, Estonia), one pair of primers were used to detect 16S rDNA. The primer concentration used was 10 µL of each primer, 12 µL of nuclease free water, and a volume of 2 µL of the extracted DNA. A PCR mix with DNA from the C. perfringens control strain was used as positive control, whereas a PCR mix containing nuclease free water was used as negative control. All samples were amplified in a PCR thermal cycler (Bioer XP Cycler, Hangzhou, China), with cycling condition of the initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 1 min, annealing at 53°C for 1 min then extension at 72°C for 1 min, and a final extension at 72°C for 10 min. The PCR products, controls and 100 bp ladder marker (Biolabs, Ipswich, MA, USA) were detected in 2.0% agarose gel (Promega) stained with red safe (CONDA Pronadisa, Madrid, Spain).

16S rDNA confirmation for C. perfringens identification

PCR confirmation for C. perfringens isolates was performed by amplification of the 16S rRNA gene using C. perfringens specific primers (Table 1). The PCR assay was performed at the final volume of 20 µL using the following mixture: 4 µL of KAPPA Fast ready mix (5X) master mix (Solis BioDyne, Tartu, Estonia), one pair of primers were used to detect 16S rDNA. The primer concentration used was 10 µL of each primer, 12 µL of nuclease free water, and a volume of 2 µL of the extracted DNA. A PCR mix with DNA from the C. perfringens control strain was used as positive control, whereas a PCR mix containing nuclease free water was used as negative control. All samples were amplified in a PCR thermal cycler (Bioer XP Cycler, Hangzhou, China), with cycling condition of the initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 1 min, annealing at 53°C for 1 min then extension at 72°C for 1 min, and a final extension at 72°C for 10 min. The PCR products, controls and 100 bp ladder marker (Biolabs, Ipswich, MA, USA) were detected in 2.0% agarose gel (Promega) stained with red safe (CONDA Pronadisa, Madrid, Spain).

Statistical analysis

Data generated from the study were tabulated with Microsoft Excel and uploaded to Statistical Package for Social Sciences (SPSS, version 20, IBM Corp, Armonk, NY, USA).

Frequency and percentage were calculated for the categorical data, and Pearson’s Chi-squared test or Fisher’s exact test were applied to determine potential factors associated with C. perfingens and to determine whether there are any statistical differences between groups. The level of significance was set at a p<0.05 to test the hypothesis of no association. Fisher’s exact test replaced the Chi-squared test when the minimum expected count was less than five.

Results

A rate of 27.2% (82/302) positivity for C. perfringens was recovered from fecal samples of examined infants aged less than one year. The rate of intestinal colonization was significantly associated with certain neonatal conditions related to low age (≤ 6 months), birth weight, absence of diarrhea and caesarean delivery (p<0.05), as shown in

Table 2. Demographic characteristics of 302 infants with positive C. perfringens cultures.

and

Table 3. Distribution of 82 C. perfringens isolates in fecal samples of infants according to their age .

. The distribution of toxin genes among the 82 C. perfringens isolates is shown in

Table 4. Distribution of potential toxin gene types among 82 C. perfringens isolates.

. A total of 78 C. perfringens isolates (95.1%) were positive for the alpha toxin gene, followed by 69.5% for the β2-gene, but only 12 (14.6%) and 2 (2.4%) were positive for the beta and epsilon toxin genes (Table 4). All C. perfringens isolates were negative for both iota and enterotoxin genes (Table 4). Toxigenic C. perfringens isolates were classified into 5 toxin genotypes based on the presence of the four main toxins detected using PCR (

Table 5. Classification of toxin genotypes among 82 C. perfringens isolates.

). Genotype A was the most prevalent type (78.1%), followed by genotype C (14.6%) and genotype D (2.4%). The other 2 genotypes (B and E) were not found. Genotype D was found in infants aged 9 and 10 months old who were fed with formula and mix.

Most C. perfringens isolates were susceptible to vancomycin, levofloxacin, metronidazole, and erythromycin. The resistance rate was 6.7% to vancomycin and levofloxacin, 16.7% to metronidazole, and 20% to erythromycin, respectively (

Table 6. Antimicrobial MIC for 30 C. perfringens isolates.

).

Discussion

Detection of C. perfringens and its various toxins became straightforward after introducing the PCR typing method, which was first developed by Yoo et al [12]. This study shows that intestinal colonization with Clostridium perfringens was detected in 27.2% of feces from infants aged ≤ 1 year at JUH. Infants aged ≤ 6 months had a higher (p<0.004) colonization rate than older infants. A similar study from Japan found C. perfringens in the feces of 18.2% healthy infants approximately 30 days old [13]. A three-year follow up study of 89 healthy infants in Japan showed that the incidence of early life intestinal colonization with α-toxigenic and enterotoxigenic C. perfringens was found only in 3% of infants at one week of age, and was later increased to 33-39% after 1-3 months [14]. This increased incidence probably occurred because the infant’s gut is first colonized primarily by facultative anaerobes that create a reduced environment and contribute to the establishment of strict anaerobic bacteria in the intestine, including Clostridium species [14].

The present study shows that the C. perfringens colonization rate was lower but not significantly in breast-fed compared to formula-fed infants (23.7% versus 28.8%). We found also that infants born by caesarean delivery were significantly (p=0.001) more frequently colonized by toxigenic C. perfringens than those born by vaginal delivery (Table 2). These results are in agreement with a recent Japanese study, which has also reported that caesarean-born infants had a higher carriage of C. perfringens compared to vaginally-born infants [14]. However, the Japanese study demonstrated that the rate of colonization by C. perfringens was much lower in breast-fed (17%) than in formula-fed infants (43%). It appears that the composition of Clostridium species in the fecal microbiota of infants can be affected by the type of feeding during the first month of birth. Higher carriage of toxigenic C. perfringens in caesarean-born infants needs further investigation of its sources and potential clinical significance.

This study shows that there was a significant association (p<0.05) between C. perfringens colonization and certain neonatal condition related to age, birth weight, mode of delivery, and hospital ward, while the presence of diarrhea, antibiotic treatment, type of feeding and gender were not significantly associated with C. perfringens colonization (p>0.05).

The pathogenicity of C. perfringens is related to the potential presence of its lethal toxin genes. The pattern of potential toxin genes is different depending on the C. perfringens toxigenic type prevalent in each community, and it is still unknown why such difference occurs and which conditions activate these genes [5,6,15].

The present study indicates that almost all C. perfringens isolates were positive for potential presence of the a-toxin gene (95.1%), followed by β2-toxin gene (69.5%), whereas the other toxin genes were detected in few samples, and no single isolate was positive for iota or enterotoxin genes (Table 3). All our C. perfringens isolates were obtained from infants without diarrhea, and this might explain the absence of enterotoxin-producing isolates in their intestine. It has been reported that α-toxin, encoded by the cpa gene, is common to all 5 C. perfringens types (A–E) [5], and especially C. perfringens type A can cause fatal diseases in human and several animal species [5,6].

This study shows also that 78.1% of C. perfringens isolates can be classified for epidemiological purposes as genotype A and cpe-negative (PCR positive for the alpha toxin gene but negative for genes encoding beta, epsilon, iota, and enterotoxins) as reported by Badagliacca et al. [15], whereas the other B to E genotypes were found less commonly (0-14.6%) in our isolates (Table 4).

It is well documented that enterotoxigenic C. perfringens is one of the most common causes of food-poisoning in humans worldwide [4,5,6]. A study in Jordan reported that no enterotoxin-positive C. perfringens found in clinical cases was associated with necrotic enteritis in commercial poultry using multiplex PCR, since all their isolates were classified as enterotoxin negative type A [16]. It would be highly important epidemiologically to initiate a large follow up study to search for the incidence of toxin types among C. perfringens isolates from food sources and food-poisoning cases in Jordan.

Most published antimicrobial susceptibility studies tested isolates from food items or animals. This study demonstrates that most C. perfringens isolates from fecal samples of infants were susceptible to vancomycin, levofloxacin, metronidazole, and erythromycin (Table 5). The minimum inhibitory concentrations for 50% of isolates (MIC₅₀) for vancomycin, levofloxacin, metronidazole, and erythromycin were 0.49, 0.61, 0.47, and 0.83 µg/mL, respectively. Only 22% of C. perfringens isolates were resistant to erythromycin. A case study of clindamycin-resistant C. perfringens human cellulitis was reported by Khanna in England, while it is well known that C. perfringens is highly susceptible to all penicillin drugs [17].

A previous study done in Jordan found that all C. perfringens isolates from animal sources showed a very high minimal inhibitory concentration (MIC₅₀> 256 mg/mL) for lincomycin, erythromycin, and tilmicosin [16]. A recent study has reported that all C. perfringens isolates from cooked beef sold in Côte d’Ivoire were vancomycin susceptible, and 80% and 45% of the isolates were resistant to norfloxacin and erythromycin, respectively [18]. A recent study done also in Brazil found that all C. perfringens isolates from insects (Tinamidae, Cracidae and Ramphastidaespecies) were susceptible to vancomycin and metronidazole, while 22.2% were resistant to erythromycin [19]. Additionally, a recent study from Thailand reported that 54.9% of C. perfringens isolates from diarrheal newborn piglets were resistant to erythromycin and exhibited a high MIC₅₀value of 128 μg/mL [20]. A study done in Egypt found that 34%, 46%, 58%, 67%, 94% and 98% of C. perfringens isolated from broiler chickens were resistant to rifampicin, chloramphenicol, colistin, ciprofloxacin, norfloxacin, and doxycycline, respectively [21]. Overall, studies from various countries showed generally an elevated rate of antibiotic resistance among C. perfringens and among other bacterial pathogens isolated from poultry [21,22].

Conclusions

This study demonstrated a high diversity of potential toxin genes found among C. perfringens isolates from fecal samples of Jordanian infants, but no single infant carried an isolate with potential enterotoxin genes causing diarrhea.